Cabaletta Bio vs Immunocore
Cabaletta Bio
Engineered T cell therapies designed for the treatment of patients with autoimmune diseases
191 employees · est. 2017 · Philadelphia, United States
Immunocore is the older company (2017 vs 2008); Immunocore is the larger of the two.
2 signals in the last 90 days
Side-by-Side Comparison
| Metric | Cabaletta Bio | Immunocore |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2008 older |
| Headquarters | ||
| Headquarters | Philadelphia, United States | Abingdon, United Kingdom |
| Employees | ||
| Employees | 191 | 607 larger |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | IPO | IPO |
| Total Funding | ||
| Total Funding | $322.00M | $975.60M |
| Funding Rounds | ||
| Funding Rounds | 8 | 10 |
| Services | ||
| Services | Development of T cell therapies for autoimmune diseases, Conducting Phase 1/2 clinical trials, CD19 chimeric antigen receptor T cell therapy development, Research and development of CABA® platform | Development of TCR therapies, Clinical trials management, Research in immunotherapy, Therapeutic pipeline development |
| Target Customers | ||
| Target Customers | Patients with autoimmune diseases, Healthcare providers specializing in rheumatology, dermatology, and neurology, Biotechnology researchers and collaborators, Investors in biopharmaceuticals | Patients with cancer, Patients with infectious diseases, Patients with autoimmune diseases, Healthcare professionals |
| Taxonomy | ||
| Taxonomy | Engineered T Cell TherapiesAutoimmune DiseasesClinical-stageCARTA StrategyCAART StrategyB Cell-mediated Autoimmune Diseases +8 | T Cell ReceptorImmunotherapyCancer TherapyOncologyMetastatic MelanomaInfectious Diseases +8 |
| Website | ||
| Website | cabalettabio.com | immunocore.com |
About Cabaletta Bio
Cabaletta Bio (Nasdaq: CABA) is at the forefront of innovation within the biotechnology sector, focusing on engineered T cell therapies aimed at treating autoimmune diseases. Founded in 2017 and headquartered in Philadelphia, PA, this clinical-stage company is pioneering potentially curative medical...
About Immunocore
Immunocore, founded in 2008 and headquartered in the United Kingdom, is a prominent player in the Biotechnology, Health Care, and Pharmaceutical industries. The company's slogan, "Science to Transform Lives," encapsulates its mission to develop groundbreaking T cell receptor (TCR) biological therapi...
Also comparing in this category
Comparing more than these two?
Get Cabaletta Bio, Immunocore and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Cabaletta Bio compare?
A PDF of Cabaletta Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Frequently Asked Questions
Compare Cabaletta Bio with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Cabaletta Bio on 9 Jun 2026, and Immunocore on 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
